Home Compliance Justice Department Declines FCPA Prosecution Against Lifecore Biomedical Under Corporate Enforcement Policy ComplianceExpert OpinionFCPA Justice Department Declines FCPA Prosecution Against Lifecore Biomedical Under Corporate Enforcement Policy November 22, 2023 50 Share FacebookLinkedinTwitter Vitalii Vodolazskyi | Shutterstock You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Compliance SEC FCPA Enforcement – 2024 Year In Review Compliance AAR’s Bribery Schemes: Bribery in the Aviation Industry (Part II of II) Compliance DOJ and SEC Close 2024 with FCPA Enforcement Action Against AAR Corp; DOJ and SEC Announces Resolution with Deepak Sharma, CEO of AAR Subsidiary...